60
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T37955 |
Sphingosine-1-phosphate (d16:1)
Sphingosine-1-phosphate (d16:1) |
||
C16 Sphingosine-1-phosphate (C16 S1P) is a derivative of sphingosine-1-phosphate that binds to S1P1/EDG-1, S1P3/EDG-3, and S1P2/EDG-5 receptors with affinities of 115%, 83%, and 103%, respectively, relative to S1P in CHO cells. C16 S1P was increased in postmortem primary open angle glaucoma trabecular meshwork samples. | |||
T6923 |
Ozanimod
奥扎莫德,RPC-1063 |
S1P Receptor; LPL Receptor | GPCR/G Protein |
Ozanimod (RPC-1063) 是一种选择性S1P1和S1P5受体激动剂,在[35S]-GTPγS 结合实验中,EC50分别为 410 pM 和 11 nM。它可研究治疗克罗恩病、溃疡性结肠炎、多发性硬化症和复发性多发性硬化症的试验。 | |||
T83880 |
C18 Ceramide-1-phosphate (d18:1/18:0) ammonium
Ceramide-1-phosphate (d18:1/18:0),N-octadecanoyl-D-erythro-Sphingosine-1-phosphate,C18 Ceramide-1-phosphate,C18 C1P,CerP(d18:1/18:0),N-stearoyl-D-erythro-Sphingosine-1-phosphate |
||
C18 Ceramide-1-phosphate (d18:1/18:0) 是一种在鼠皮肤中发现的长链ceramide-1-phosphate。它能在0.5至5 µM的浓度范围内促进分离的小鼠骨髓来源的多能间充质细胞和人脐静脉内皮细胞(HUVECs)的迁移。与胰腺癌干细胞相比,CFPAC-1胰管腺癌细胞中C18 Ceramide-1-phosphate (d18:1/18:0)的水平有所增加。在Langendorff分离的灌流小鼠心脏的离体缺血模型中,心肌中C18 ceramide-1-phosphate (d18:1/18:0)的水平有所增加。 | |||
T83910 |
S1PL-IN-31
Sphingosine-1-Phosphate Lyase Inhibitor 31,S1PL Inhibitor 31,S1P Lyase Inhibitor 31 |
||
S1PL-IN-31是一种鞘氨醇-1-磷酸(S1P)裂解酶的抑制剂(IC50 = 210 nM),同时也是Smoothened(Smo)受体的对抗剂(IC50 = 440 nM)。在体内,S1PL-IN-31 (每天2 mg/kg)能够防止实验性自身免疫性脑炎(EAE)模型大鼠中,由髓鞘少突胶质细胞糖蛋白(MOG)肽段MOG29-152诱发的颈部及胸部淋巴细胞渗透和神经肌肉虚弱。该化合物降低了大鼠的淋巴细胞总数及CD4+ T细胞、CD8+ T细胞和B细胞的水平。S1PL-IN-31 (每天3及10 mg/kg剂量)在雄性和雌性大鼠心脏和淋巴结中增加了S1P水平,并且在雌性大鼠中降低了心率。 | |||
T27106 |
CYM50374
|
||
CYM50374对Sphingosine-1-phosphate receptor 4(S1P4 )具有抑制作用,IC50为 µM。 | |||
T27864 |
LX-2931
LX 3305,LX2931,LX-3305,ACB20034,LX 2931,LX3305 |
S1P Receptor | GPCR/G Protein |
LX-2931(LX-3305) 是一种鞘氨醇-1-磷酸裂解酶(S1P)抑制剂,可用于治疗类风湿性关节炎。 | |||
T10305 |
Amiselimod hydrochloride
MT-1303 hydrochloride |
S1P Receptor; LPL Receptor | GPCR/G Protein |
Amiselimod hydrochloride (MT-1303 hydrochloride) 是一种鞘氨醇 1-磷酸受体 1 (S1P1) 调节剂。 | |||
T12086 |
Mocravimod hydrochloride
KRP-203 |
Others; LPL Receptor | GPCR/G Protein; Others |
Mocravimod hydrochloride (KRP-203) 是 1-磷酸鞘氨醇受体 1 型 (S1PR1) 的有效和口服活性激动剂。 | |||
T15031 |
CYM50260
|
Others; LPL Receptor | GPCR/G Protein; Others |
CYM50260 是有效的、强选择性的鞘氨醇-1-磷酸 4 受体 (S1P4-R) 激动剂 (EC50= 45 nM),对 S1P1-R,S1P2-R,S1P3-R 和 S1P5-R 无活性。 | |||
T7360 |
GSK2018682
|
S1P Receptor; LPL Receptor | GPCR/G Protein |
GSK2018682 是 1-磷酸鞘氨醇受体S1P1和S1P5激动剂,pEC50值分别为 7.7 和 7.2,可用于多发性硬化的研究。 | |||
T28643 |
Ex26
S1P1-IN-Ex26 |
S1P Receptor | GPCR/G Protein |
Ex26 (S1P1-IN-Ex26) 是一种具有选择性和高效性的 sphingosine 1-phosphate receptor 1 (S1P1) 拮抗剂,可破坏 SR-B1-S1PR1相互作用,抑制 S1P-S1PR1 信号转导。Ex26 可用于实验性自身免疫性脑脊髓炎、动脉粥样硬化和胃癌。 | |||
TQ0227 |
Etrasimod
APD334 |
S1P Receptor; LPL Receptor | GPCR/G Protein |
Etrasimod (APD334) 是一种特异性和口服的S1P1受体拮抗剂,在CHO 细胞中的IC50值为1.88 nM。 | |||
T9464 |
CYM50358
|
LPL Receptor | GPCR/G Protein |
CYM50358 是选择性的S1PR4拮抗剂,IC50值为 25 nM,可用于流感研究。 | |||
T63047 |
SLP9101555
|
S1P Receptor; LPL Receptor | GPCR/G Protein |
SLP9101555 是一种有效且具有选择性的鞘氨醇激酶 2(SphK2)抑制剂,Ki 为90 nM。SLP9101555对SphK2具有很高的亲和力,是 SphK1 的 200 倍。SLP9101555 显著降低细胞外 S1P 鞘氨醇 1- 磷酸(S1P)水平。 | |||
T3258 |
Ponesimod
ACT-128800 |
S1P Receptor; LPL Receptor | GPCR/G Protein |
Ponesimod (ACT-128800) 是一种选择性 S1P1可口服激动剂,在放射性配体结合试验中的 IC50值为 6 nM。它可高效激活 S1P1介导的信号转导,EC50为5.7 nM。它可预防淋巴细胞介导的组织炎症,具有潜在的免疫调节活性。 | |||
T14924 |
Cenerimod
ACT-334441 |
S1P Receptor | GPCR/G Protein |
Cenerimod (ACT-334441) 是一种具有口服活性、选择性和高效性的磷酸鞘氨醇 1 受体(S1P1)激动剂(EC50:1 nM)。Cenerimod 对多种 S1P 的亚型具有抑制作用,可用于研究鼠类实验性自身免疫性脑脊髓炎 (EAE)和鼠类硬皮病。 | |||
T22102 |
ML-178
CYM50179 |
Others | Others |
ML-178 是一种二氯苯,是鞘氨醇-1-磷酸受体4(S1PR4)的强效选择性激动剂,EC50 为 46 nM,在25 μM 的浓度下对其他 S1P 受体没有影响。 | |||
T10385 |
ASP-4058
|
S1P Receptor; LPL Receptor | GPCR/G Protein |
ASP-4058 是一种鞘氨醇磷酸受体 1 和 5 (S1P1 and S1P5) 的二代激动剂,具有选择性、安全性和口服活性。ASP-4058能改善小鼠实验性自身免疫性脑脊髓炎。 | |||
T2539 |
Fingolimod hydrochloride
Fingolimod (FTY720) HCl,FTY720,盐酸芬戈莫德 |
TRP/TRPV Channel; S1P Receptor; PAK; LPL Receptor | Cytoskeletal Signaling; GPCR/G Protein; Membrane transporter/Ion channel |
Fingolimod hydrochloride (FTY720) 是一种新型免疫调节剂,是一种 1-磷酸鞘氨醇(S1P) 拮抗剂,作用于 K562 和 NK 细胞,IC50为 0.033 nM。它诱导 S1P1 的内化,从而抑制 S1P 活性。它被鞘氨醇激酶磷酸化,尤其是被 SK2 磷酸化,从而可与 S1PR1、3、4 和 5 结合 | |||
T15032 |
CYM50308
|
S1P Receptor; LPL Receptor | GPCR/G Protein |
CYM50308 是选择性和高亲和力的鞘氨醇-1-磷酸受体 4 激动剂,EC50为 56 nM。它对 S1P4-R 的选择性比 S1P5-R 高 37 倍。 | |||
T62552 |
Ozanimod hydrochloride
|
||
Ozanimod (RPC-1063) hydrochloride 是一种鞘氨醇 1-磷酸 (S1P) 受体调节剂,能够高亲和力地选择性结合 S1P 受体亚型 1 (S1P1) 和 S1P5 (S1P5)。Ozanimod hydrochloride 能够调节 hS1P1 受体 (EC50: 1.03 nM) 和 hS1P5 受体 (EC50: 8.6 nM)。Ozanimod hydrochloride 能够用于研究复发性多发性硬化 (MS)。 | |||
T38294 |
4-Deoxypyridoxine hydrochloride
|
S1P Receptor | GPCR/G Protein |
4-Deoxypyridoxine hydrochloride 通过抑制 S1P 裂解酶 (SPL) 活性来抑制细胞内 S1P 的降解,与 S1P 一样,减少化学诱导的胰岛素瘤细胞系的细胞凋亡。 | |||
T13327 |
W146
W 146,W-146 |
Others | Others |
W146 is a selective sphingosine-1-phosphate receptor 1 (S1PR1) antagonist (EC50: 398 nM). | |||
T31107 |
CS-0777
CS0777,CS 0777 |
||
CS-0777 is a potent, selective, and orally active S1P1 agonist (sphingosine 1-phosphate receptor modulator). | |||
T71564 | GSK2018682 HCl | ||
GSK2018682 is a novel sphingosine-1-phosphate receptor 1 (s1p1) and 5 (s1p5) agonist. | |||
T68678 | VPC 24191 | ||
VPC 24191 is a sphingosine 1-phosphate (S1P1/3) receptor agonist. | |||
T10912 |
S1PR1-MO-1
|
Others | Others |
S1PR-MO-1 is a modulator of sphingosine-1-phosphate receptor and is used to study hyperproliferative inflammatory diseases. | |||
T68448 |
XAX-162
|
||
XAX-162 is an agonist of Sphingosine 1-phosphate receptor 2 (S1PR2) | |||
T71392 |
(R)-FTY-720 Vinylphosphonate
|
||
(R)-FTY-720 Vinylphosphonate is a sphingosine 1-phosphate type 1 (S1P1) receptor agonist and lacks anti-apoptotic activity. | |||
T39097 |
Zectivimod
|
||
Zectivimod, a sphingosine-1-phosphate receptor agonist, holds the potential for studying autoimmune diseases, chronic inflammatory diseases, and immunoregulation disorders. | |||
T10387 |
ASP1126
|
Others | Others |
ASP1126 is a selective and orally active sphingosine-1-phosphate (S1P) agonist (EC50s: 7.12 nM, 517 nM for hS1P1 and hS1P3). | |||
T14930 |
Ceralifimod
ONO-4641 |
Others | Others |
Ceralifimod (ONO-4641) is a potent agonist for sphingosine 1-phosphate receptors 1 and 5 (EC50s: 27.3, 334 pM for human S1P receptor 1 and 5). | |||
T68698 | VPC 23153 | ||
VPC 23153 is a sphingosine 1-phosphate 4 receptor agonist. This hygroscopic phospholipid causes contraction of pulmonary artries in rats. | |||
T37952 |
Sphinganine-1-phosphate (d17:0)
Sphinganine-1-phosphate (d17:0) |
||
Sphinganine-1-phosphate (d17:0) is a sphingolipid analog of sphinganine-1-phosphate (d18:0) and sphingosine-1-phosphate (d18:1) that has a 17-carbon base. Sphinganine-1-phosphate (d17:0) levels are lower in surgical and cadaver trabecular meshwork samples isolated from patients with primary open angle glaucoma compared with control samples. | |||
T28080 |
Mocravimod
KRP 203 free base,KRP-203,KRP203 |
||
Mocravimod is an agonist of sphingosine 1-phosphate receptor type 1. Mocravimod ameliorates atherosclerosis in LDL-R-/- mice. KRP-203 attenuates rat autoimmune myocarditis. KRP-203 combined with cyclosporine prolonged graft survival and abrogated transpla | |||
T70613 |
SLP120701 HCl
|
||
SLP120701 is a potent and selective sphingosine kinase 2 inhibitor. Sphingosine-1-phosphate (S1P) is a ubiquitous, endogenous small molecule that is synthesized by two isoforms of sphingosine kinase (SphK1 and 2). Intervention of the S1P signaling pathway has attracted significant attention because alteration of S1P levels is linked to several disease states including cancer, fibrosis, and sickle cell disease. | |||
T36833 |
A6770
|
||
A6770 is an inhibitor of sphingosine-1-phosphate (S1P) lyase.1It induces accumulation of [3H]sphinganine-1-phosphate ([3H]dhS1P), an S1P lyase substrate, in IT-79MTNC3 cells that endogenously express high levels of S1P lyase (EC50= <0.01 μM), an effect that is reduced in the presence of vitamin B6(EC50= <100 μM). 1.Ohtoyo, M., Tamura, M., Machinaga, N., et al.Scintillation proximity assay to detect the changes in cellular dihydrosphingosine 1-phosphate levelsLipids51(10)1207-1216(2016) | |||
T41237 |
W146 TFA
|
||
W146 TFA 是选择性 1-磷酸-鞘氨醇受体亚型 1 (S1PR1) 的拮抗剂,EC50值为 398 nM。 | |||
T78160 | SLB1122168 formic | LPL Receptor | GPCR/G Protein |
SLB1122168 formic为一种高效的Spns2介导的S1P释放抑制剂,其半抑制浓度(IC50)为94 nM。 | |||
T70614 |
SLR080811 HCl
|
||
SLR080811 is a SphK inhibitor. Sphingosine-1-phosphate (S1P) is a ubiquitous, endogenous small molecule that is synthesized by two isoforms of sphingosine kinase (SphK1 and 2). Intervention of the S1P signaling pathway has attracted significant attention because alteration of S1P levels is linked to several disease states including cancer, fibrosis, and sickle cell disease. | |||
T61406 |
RBM10-8
|
||
RBM10-8不可逆地抑制人鞘氨醇-1-磷酸裂解酶(hS1PL),同时也作为酶底物发挥作用。 | |||
T28838 |
SPM-242
SPM 242 |
||
SPM-242 is an orthosteric agonist of Sphingosine 1-phosphate (S1P) and a bitopic antagonist. S1P is a lysophospholipid signaling molecule that regulates important biological functions, including vascular development and lymphocyte trafficking, by activat | |||
T71301 | Opaganib HCl | ||
ABC294640, also known as Opaganib, is an orally available, aryladamantane compound and selective inhibitor of sphingosine kinase-2 (SK2) with potential antineoplastic activity. Upon administration, ABC294640 competitively binds to and inhibits SK2, thereby preventing the phosphorylation of the pro-apoptotic amino alcohol sphingosine to sphingosine 1-phosphate (S1P), the lipid mediator that is pro-survival and critical for immunomodulation. This may eventually lead to the induction of apoptosis a... | |||
T35781 |
Sphinganine (d20:0)
Sphinganine (d20:0) |
||
Sphinganine (d20:0) is a natural isomer of dihydro-D-erythro-sphinganine (sphinganine (d18:0); that is a precursor of ceramide and sphingosine as well as a substrate for sphingosine kinases, which generate sphingosine-1-phosphate (d18:1) . In S. cerevisiae, the amount of sphinganine (d20:0) increases 10.8-fold in response to heat stress, indicating it is involved in heat stress adaptation. Sphinganine levels increase significantly in response to certain mycotoxins, including fumonisins as well ... | |||
T38000 |
Lysosphingomyelin (d18:1)
|
||
Sphingomyelins are complex membrane lipids composed of phosphorylcholine, sphingosine, and an acylated group, such as a fatty acid. Lysosphingomyelin is a naturally-occurring lipid which is produced by the removal of the acylated group of sphingomyelin by a deacylase. Lysosphingomyelin may, in turn, serve as a substrate for autotaxin, which removes choline to produce sphingosine-1-phosphate. The receptors and signaling pathways that are activated by lyso-sphingosine are diverse and vary between ... | |||
T41145 |
TASP 0277308
|
||
TASP 0277308 is a potent and selective sphingosine 1-phosphate 1 (S1P1) receptor antagonist (IC50 = 7.8 nM). TASP 0277308 inhibits S1P-induced chemotaxis (IC50 = 1.1-1.6 nM), HUVEC cell proliferation (IC50 = 3-3.6 nM) and suppresses angiogenesisin vivo. TASP 0277308 also blocks VEGF-induced tube-formation of HUVECsin vitroand reverses or impairs the development of arthritis or mechano-allodynia. | |||
T38716 |
SAR247799
SAR247799,S1P1 agonist 3 |
||
SAR247799 (S1P1 agonist 3) is an orally-active, selective G-protein-biased agonist for the sphingosine-1 phosphate receptor-1 (S1P1). It demonstrates EC50 values ranging from 12.6 to 493 nM in S1P1-overexpressing cells and HUVECs. SAR247799 holds promise as a valuable tool for investigating endothelial protection, particularly in the context of type-2 diabetes and metabolic syndrome[4]. | |||
T73360 |
RP101442
|
||
RP101442 是 Ozanimod 的活性代谢物,是一种选择性强的 S1PR1激动剂,对 S1PR1和 S1PR5的 EC50分别为 2.6 nM 和 171 nM。 | |||
T70789 |
VPC03090
|
||
VPC03090 is a Sphingosine-1-Phosphate Receptor Inhibitor. VPC03090 is an analog of FTY-720, acts as antagonist for S1PR1 and S1PR3. VPC03090-P, converted from VPC03090 through the phosphorylation by SK-2, causes a reduction in tumor growth in mice with mammary cancer, and its oral bioavailability is determined to be 30 hours. | |||
T37548 |
azido-FTY720
azido-FTY720 |
||
FTY720 is a derivative of ISP-1 (myriocin), a fungal metabolite of the Chinese herb Iscaria sinclarii as well as a structural analog of sphingosine. It is a novel immune modulator that prolongs allograft transplant survival in numerous models by inhibiting lymphocyte emigration from lymphoid organs. FTY720 is phosphorylated by sphingosine kinase, which then acts as a potent agonist at four of the sphingosine-1-phosphate (S1P) receptors (S1P1, S1P3, S1P4, and S1P5). Down-regulation of S1P1 recept... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T21500 |
Sphingosine-1-phosphate
S1P |
Endogenous Metabolite; S1P Receptor; LPL Receptor | GPCR/G Protein; Metabolism |
Sphingosine-1-phosphate (S1P) 是 S1P1-5 受体 (S1P1-5 receptors) 的激动剂和 GPR3、GPR6、GPR12 的配体。Sphingosine-1-phosphate 是细胞内的第二信使,动员 Ca2+ 作为 G 蛋白偶联受体的细胞外配体。Sphingosine-1-phosphate 是由鞘磷脂 (HY-113498) 或其他膜磷脂生成的重要脂质介质。 | |||
T7939 |
Fingolimod
2-氨基-2-[2-(4-辛基苯基)乙基]-1,3-丙二醇,FTY-720A,FTY-720,芬戈莫德 |
S1P Receptor; PAK; LPL Receptor | Cytoskeletal Signaling; GPCR/G Protein |
Fingolimod (FTY-720A) 是一种 1-磷酸鞘氨醇 (S1P) 拮抗剂,作用于 K562 和 NK 细胞,IC50为 0.033 nM。它还是pak1激活剂和免疫抑制剂。 |